Impact of catheterization on shear-mediated arterial dilation in healthy young men.


Journal

European journal of applied physiology
ISSN: 1439-6327
Titre abrégé: Eur J Appl Physiol
Pays: Germany
ID NLM: 100954790

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 27 04 2020
accepted: 10 08 2020
pubmed: 29 8 2020
medline: 30 7 2021
entrez: 29 8 2020
Statut: ppublish

Résumé

Animal studies have shown that endothelial denudation abolishes vasodilation in response to increased shear stress. Interestingly, shear-mediated dilation has been reported to be reduced, but not abolished, in coronary artery disease (CAD) patients following catheterization. However, it is not known whether this resulted from a priori endothelial dysfunction in this diseased population. In this study, we evaluated shear-mediated dilation following catheterization in healthy young men. Twenty-six (age: 24.4 ± 3.8 years, BMI: 24.3 ± 2.8 kg m FMD was reduced in the catheterized arm [9.3 ± 4.1% to 4.3 ± 4.1% (P < 0.001)] post-catheterization, whereas no change was observed in the control arm [8.4 ± 3.8% to 7.3 ± 3.8% (P = 0.168)]. FMD was completely abolished in the catheterized arm in five participants. Baseline diameter (P = 0.001) and peak diameter during FMD (P = 0.035) were increased in the catheterized arm 7 days post-catheterization (baseline: 2.3 ± 0.3 to 2.6 ± 0.2 mm, P < 0.001, peak: 2.5 ± 0.3 to 2.7 ± 0.3 mm, P = 0.001), with no change in the control arm (baseline: 2.3 ± 0.3 to 2.3 ± 0.3 mm, P = 0.288, peak: 2.5 ± 0.3 to 2.5 ± 0.3 mm, P = 0.608). This is the first study in young healthy individuals with intact a priori endothelial function to provide evidence of impaired shear-mediated dilation following catheterization. When combined with earlier studies in CAD patients, our data suggest the catheterization impairs artery function in humans.

Identifiants

pubmed: 32857185
doi: 10.1007/s00421-020-04473-8
pii: 10.1007/s00421-020-04473-8
pmc: PMC7557491
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2525-2532

Subventions

Organisme : National Health and Medical Research Council Australia
ID : 1080914

Références

Circulation. 2004 Mar 23;109(11):1371-8
pubmed: 15007010
Eur Heart J. 2019 Aug 7;40(30):2534-2547
pubmed: 31211361
J Vasc Res. 1996 Jan-Feb;33(1):42-6
pubmed: 8603125
Am J Physiol Heart Circ Physiol. 2011 Jan;300(1):H2-12
pubmed: 20952670
Open Cardiovasc Med J. 2010 Dec 23;4:302-12
pubmed: 21339899
Hypertension. 2013 Aug;62(2):345-51
pubmed: 23774225
Int J Cardiol. 2015 Jan 20;179:203-10
pubmed: 25464446
JACC Cardiovasc Interv. 2009 Nov;2(11):1067-73
pubmed: 19926046
Atherosclerosis. 2013 Feb;226(2):425-7
pubmed: 23261170
Int J Vasc Med. 2012;2012:589213
pubmed: 22315688
Circ Cardiovasc Interv. 2012 Oct;5(5):713-9
pubmed: 23011264
J Physiol. 2004 Jun 1;557(Pt 2):599-611
pubmed: 15047770
Appl Physiol Nutr Metab. 2012 Oct;37(5):860-71
pubmed: 22703030
Cardiovasc Res. 2000 Aug 18;47(3):436-45
pubmed: 10963717
Arterioscler Thromb Vasc Biol. 2002 Jan;22(1):21-7
pubmed: 11788456
Am J Physiol Heart Circ Physiol. 2010 Jan;298(1):H119-26
pubmed: 19880668
Circ Cardiovasc Interv. 2010 Apr;3(2):148-56
pubmed: 20407113
J Am Coll Cardiol. 2005 Aug 16;46(4):648-55
pubmed: 16098430
Am J Cardiol. 2007 Feb 15;99(4):457-9
pubmed: 17293183
Sports Med. 2010 Jun 1;40(6):481-92
pubmed: 20524713
J Appl Physiol (1985). 2020 Feb 1;128(2):422-428
pubmed: 31917624
Circulation. 1997 Nov 18;96(10):3593-601
pubmed: 9396460
J Appl Physiol (1985). 2001 Aug;91(2):929-37
pubmed: 11457812
Catheter Cardiovasc Interv. 1999 Feb;46(2):173-8
pubmed: 10348538
Eur J Appl Physiol. 2014 May;114(5):941-50
pubmed: 24477571
Hypertension. 2014 Feb;63(2):376-82
pubmed: 24277765
Clin Sci (Lond). 2010 Feb 23;118(10):633-40
pubmed: 20059449
Radiology. 1999 Sep;212(3):655-64
pubmed: 10478228
J Am Heart Assoc. 2016 Jan 25;5(1):
pubmed: 26811162
J Physiol. 2016 Apr 15;594(8):2245-57
pubmed: 25809076
Cureus. 2017 Jun 3;9(6):e1309
pubmed: 28690943
J Appl Physiol (1985). 2002 Mar;92(3):1331-8
pubmed: 11842075
J Am Heart Assoc. 2017 Oct 28;6(11):
pubmed: 29080864
Exp Physiol. 2011 Feb;96(2):57-70
pubmed: 20971800
Hypertension. 1986 Jan;8(1):37-44
pubmed: 3080370
Atherosclerosis. 1997 Feb 28;129(1):111-8
pubmed: 9069525
Circulation. 1994 Jun;89(6):2799-808
pubmed: 8205694
Circulation. 2005 Jan 4;111(1):70-5
pubmed: 15630038
Free Radic Res. 2004 May;38(5):517-25
pubmed: 15293560
Physiol Rev. 2017 Apr;97(2):495-528
pubmed: 28151424

Auteurs

Andrea Tryfonos (A)

Research Institute for Sport and Exercise Science, Liverpool John Moores University, Liverpool, L3 3AF, UK.

Matthew Cocks (M)

Research Institute for Sport and Exercise Science, Liverpool John Moores University, Liverpool, L3 3AF, UK.

Debar Rasoul (D)

Liverpool Heart and Chest Hospital, Liverpool, L14 3PE, UK.

Joseph Mills (J)

Liverpool Heart and Chest Hospital, Liverpool, L14 3PE, UK.

Daniel J Green (DJ)

School of Human Sciences (Exercise and Sport Science), The University of Western Australia, Crawley, WA, 6009, Australia.

Ellen A Dawson (EA)

Research Institute for Sport and Exercise Science, Liverpool John Moores University, Liverpool, L3 3AF, UK. e.dawson@ljmu.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH